ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease.

Publisher: Elsevier Country of Publication: England NLM ID: 9815616 Publication Model: Electronic Cited Medium: Internet ISSN: 1532-429X (Electronic) Linking ISSN: 10976647 NLM ISO Abbreviation: J Cardiovasc Magn Reson Subsets: MEDLINE

Publication: 2024- : London : Elsevier
Original Publication: New York : M. Dekker, Inc., c1998-

Myocardial Ischemia* ; Cardiology* ; Acute Coronary Syndrome* ; Coronary Disease*; Humans ; United States ; Predictive Value of Tests ; Risk Assessment

The American College of Cardiology (ACC) Foundation, along with key specialty and subspecialty societies, conducted an appropriate use review of stress testing and anatomic diagnostic procedures for risk assessment and evaluation of known or suspected chronic coronary disease (CCD), formerly referred to as stable ischemic heart disease (SIHD). This document reflects an updating of the prior Appropriate Use Criteria (AUC) published for radionuclide imaging, stress echocardiography (echo), calcium scoring, coronary computed tomography angiography (CCTA), stress cardiac magnetic resonance (CMR), and invasive coronary angiography for SIHD. This is in keeping with the commitment to revise and refine the AUC on a frequent basis. As with the prior version of this document, rating of test modalities is provided side-by-side for a given clinical scenario. These ratings are explicitly not considered competitive rankings due to the limited availability of comparative evidence, patient variability, and the range of capabilities available in any given local setting ^1-4 .This version of the AUC for CCD is a focused update of the prior version of the AUC for SIHD ⁴ . Key changes beyond the updated ratings based on new evidence include the following: 1. Clinical scenarios related to preoperative testing were removed and will be incorporated into another AUC document under development. 2. Some clinical scenarios and tables were removed in an effort to simplify the selection of clinical scenarios. Additionally, the flowchart of tables has been reorganized, and all clinical scenario tables can now be reached by answering a limited number of clinical questions about the patient, starting with the patient's symptom status. 3. Several clinical scenarios have been revised to incorporate changes in other documents such as pretest probability assessment, atherosclerotic cardiovascular disease (ASCVD) risk assessment, syncope, and others. ASCVD risk factors that are not accounted for in contemporary risk calculators have been added as modifiers to certain clinical scenarios. The 64 clinical scenarios rated in this document are limited to the detection and risk assessment of CCD and were drawn from common applications or anticipated uses, as well as from current clinical practice guidelines. ⁵ These clinical scenarios do not specifically address patients having acute chest pain episodes. They may, however, be applicable in the inpatient setting if the patient is not having an acute coronary syndrome and warrants evaluation for CCD.Using standardized methodology, clinical scenarios were developed to describe common patient encounters in clinical practice focused on common applications and anticipated uses of testing for CCD. Where appropriate, the scenarios were developed on the basis of the most current ACC/American Heart Association guidelines. A separate, independent rating panel scored the clinical scenarios in this document on a scale of 1 to 9, following a modified Delphi process consistent with the recently updated AUC development methodology. Scores of 7 to 9 indicate that a modality is considered appropriate for the clinical scenario presented, midrange scores of 4 to 6 indicate that a modality may be appropriate for the clinical scenario, and scores of 1 to 3 indicate that a modality is rarely appropriate.
(© 2023. Society for Cardiovascular Magnetic Resonance.)

Eur Heart J. 2018 Sep 14;39(35):3322-3330. (PMID: 29850808)
J Nucl Cardiol. 2016 Jun;23(3):606-39. (PMID: 26914678)
J Am Soc Echocardiogr. 2011 Jan;24(1):1-10. (PMID: 21172594)
J Am Coll Cardiol. 2018 Feb 27;71(8):935-948. (PMID: 29471942)
Circulation. 2014 Jul 22;130(4):350-79. (PMID: 25047587)
J Am Soc Echocardiogr. 2017 Feb;30(2):101-138. (PMID: 28164802)
N Engl J Med. 2020 Apr 9;382(15):1395-1407. (PMID: 32227755)
J Am Coll Cardiol. 2005 Oct 18;46(8):1606-13. (PMID: 16226195)
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129. (PMID: 34895950)
J Cardiovasc Comput Tomogr. 2016 Jul-Aug;10(4):269-81. (PMID: 27318587)
J Cardiovasc Comput Tomogr. 2014 Sep-Oct;8(5):342-58. (PMID: 25301040)
J Cardiovasc Magn Reson. 2009 Mar 03;11:5. (PMID: 19257889)
J Am Coll Cardiol. 2012 May 15;59(20):1833-47. (PMID: 22445856)
Ann Intern Med. 1992 Dec 15;117(12):990-6. (PMID: 1280018)
N Engl J Med. 2020 Apr 9;382(15):1408-1419. (PMID: 32227753)
J Cardiovasc Comput Tomogr. 2017 Mar - Apr;11(2):157-168. (PMID: 28283309)
J Cardiovasc Comput Tomogr. 2011 Jul-Aug;5(4):198-224. (PMID: 21723512)
Heart Rhythm. 2015 Jun;12(6):e41-63. (PMID: 25980576)
Am J Cardiol. 2013 Oct 15;112(8):1263-70. (PMID: 23927786)
J Am Coll Cardiol. 2013 Mar 26;61(12):1305-17. (PMID: 23433633)
J Am Coll Cardiol. 2021 Nov 30;78(22):e187-e285. (PMID: 34756653)
J Am Soc Echocardiogr. 2020 Jan;33(1):1-41.e8. (PMID: 31740370)
J Cardiovasc Magn Reson. 2013 Oct 08;15:91. (PMID: 24103764)
J Nucl Cardiol. 2016 Oct;23(5):1187-1226. (PMID: 27392702)
J Am Coll Cardiol. 2019 Jan 22;73(2):214-237. (PMID: 30573393)
Catheter Cardiovasc Interv. 2016 Sep;88(3):407-23. (PMID: 27137680)
J Am Coll Cardiol. 2014 Feb 4;63(4):380-406. (PMID: 24355759)
J Nucl Cardiol. 2018 Oct;25(5):1784-1846. (PMID: 29802599)
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350. (PMID: 30423393)
Eur Heart J. 2009 Nov;30(21):2631-71. (PMID: 19713422)
J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220. (PMID: 29097296)
J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):435-449. (PMID: 27780758)
JAMA Cardiol. 2016 May 1;1(2):207-10. (PMID: 27437893)
J Am Coll Cardiol. 2017 Aug 1;70(5):e39-e110. (PMID: 28286221)
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. (PMID: 23747642)
Circulation. 2013 Aug 20;128(8):873-934. (PMID: 23877260)
Eur Heart J. 2020 Jan 14;41(3):407-477. (PMID: 31504439)
J Am Coll Cardiol. 2017 Sep 26;70(13):1647-1672. (PMID: 28870679)
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. (PMID: 30894318)
Catheter Cardiovasc Interv. 2011 Mar 1;77(4):546-56. (PMID: 21254324)

Keywords: Appropriate Use Criteria; CCD; Chronic coronary disease; Multimodality

Date Created: 20231020 Date Completed: 20231023 Latest Revision: 20240117

20240117

PMC10585920

10.1186/s12968-023-00958-5

37858155